icon-    folder.gif   Conference Reports for NATAP  
  Conference on Retroviruses
and Opportunistic Infections
February 12-16, 2022
Back grey_arrow_rt.gif
Adolescent and Parent Experiences with Long-acting Injectables in the MOCHA Study
  CROI 2022 Feb 11-16
Elizabeth D. Lowenthal1,2, Jennifer Chapman2, Katherine Calabrese3, Ryan Milligan4, Allison Agwu5, Andres Camacho-Gonzalez6, Christiana Smith-Anderson7, Jared Kneebone8, Cindy McCoig9, Conn M. Harrington10, Rodica Van Solingen-Ristea11, Adeola Adeyeye12, Jack Moye13, Carolyn Bolton Moore14, Aditya H. Gaur15
1University of Pennsylvania, Philadelphia, PA, USA, 2Children's Hospital of Philadelphia, Philadelphia, PA, USA, 3FHI 360, Durham, NC, USA, 4Frontier Science and Technology Research Foundation, Inc, Brookline, MA, USA, 5The Johns Hopkins University School of Medicine, Baltimore, MD, USA, 6Emory University, Atlanta, GA, USA, 7University of Colorado, Aurora, CO, USA, 8Frontier Science and Technology Research Foundation, Inc, Buffalo, NY, USA, 9ViiV Healthcare, Madrid, Spain, 10ViiV Healthcare, Research Triangle Park, NC, USA, 11Janssen, Beerse, Belgium, 12National Institutes of Health, Rockville, MD, USA, 13National Institutes of Health, Bethesda, MD, USA, 14Centre for Infectious Disease Research in Zambia, Lusaka, Zambia, 15St Jude Children's Research Hospital, Memphis, TN, USA